Heska Corporation Fourth Quarter and Full-Year 2020 Financial Results and Earnings Call Scheduled for February 23, 2021
01/26/2021 - 08:00 AM
LOVELAND, Colo. , Jan. 26, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its fourth quarter and full-year 2020 financial performance in a press release before the market opens on Tuesday, February 23, 2021 and to host an earnings call to discuss the results following the release at 9 a.m. MT / 11 a.m. ET .
To access the conference call:
From within the United States , please dial 1-800-289-0438the United States , please dial 1-323-794-2423
The earnings call will be webcast live from the Company's investor relations website at: Heska Fourth Quarter and Full-Year 2020 Earnings Call Webcast .
A telephonic replay will be available at 2 p.m. ET on February 23 through 11:59 p.m. ET on Tuesday , March 9, 2021 and the webcast will be archived on the Company's website for 90 days.
To access the replay:
From within the United States , please dial 1-844-512-2921the United States , please dial 1-412-317-6671
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
http://www.prnewswire.com/news-releases/heska-corporation-fourth-quarter-and-full-year-2020-financial-results-and-earnings-call-scheduled-for-february-23-2021-301214825.html
SOURCE Heska Corporation
HSKA Rankings
N/A Ranked by Stock Gains
HSKA Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Loveland
About HSKA
heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a
